THE API POWDER DIARIES

“The existing circumstance has uncovered some structural weaknesses in the EU’s medicines supply chain plus a significant dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides stated. She encouraged that supply chain troubles be resolved in an EU pharmaceutical strategy expected being released by the